Cash & equivalents decreased 41.2%
Cash & equivalents changed -41.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -41.2% from the comparable as-filed period.
Gross margin changed +1032 basis points from the comparable as-filed period.
Gross profit changed +96.2% from the comparable as-filed period.
Inventory changed +25.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +180.8% from the comparable as-filed period.
Operating income changed +239.1% from the comparable as-filed period.
Operating margin changed +2988 basis points from the comparable as-filed period.
Research & development changed +30.8% from the comparable as-filed period.
Revenue changed +58.4% from the comparable as-filed period.
Stock-based compensation changed +12.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.